Fable5 is probably the most powerful AI platform presently, but sadly does not answer requests about biology, pharmacology and similar, it routes to Opus 4.8. So I put this question to the next most powerful AI presently, not the top Ultra model, but the High model, which I have access to.
MY QUESTION:
Rapamycin and diet + lifestyle interventions.
Based on SOTA literature on Rapamycin, can we achieve a similar mTOR inhibiting effect by acting upon lifestyle variables?
Describe the analogies and the differences.
Describe pros and cons of Rapa and diet and lifestyle parameters
Describe if the inhibiting effects can be achieved by acting upon the upstream signals (for example: IGF1/insulin, sugar, Leucine and other BCAAs…)
Describe the balance of pros and cons of both approaches (RAPA OR diet+lifestyle) for the following tiers of population: a)low risk appetite; b)medium risk appetite; c)high risk appetite.
Examine if a combination of other drugs OR supplements can reach some level of inhibition on mTOR and its upstream signals.
At the end, describe if, with the future outlook of extremely fast development of medical discoveries with the help of AI, it is better to use RAPA or diet + lifestyle interventions.
ANSWER:
ChatGPT 5.6 high provided almost a treatise as an answer. Perhaps the most complete SOTA summary of RAPA versus lifestyle adoption. With the suggestions for the 3 tiers of risk-appetite. I’m going to attach the complete PDF to those who may be interested.
Rapamycin_vs_Lifestyle_mTOR_Clinical_Briefing.pdf (178.1 KB)